tiprankstipranks

Elizabeth Reed Insider Profile

4 Followers
Elizabeth Reed, VP, General Counsel at Eiger Biopharmaceuticals, holds 169.00 shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds 78.63K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Elizabeth Reed ― shares of Eiger Biopharmaceuticals on ― for an estimated value of ―.
tipranks
Elizabeth Reed

Elizabeth Reed
Eiger Biopharmaceuticals (EIGRQ)
VP, General Counsel

Not Ranked
Elizabeth Reed has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Elizabeth Reed's holdings

Insider Roles

Travere Therapeutics
(TVTX)
SVP, GC & CORPORATE SECRETARY
Roles that Elizabeth Reed holds in companies

Most Profitable Insider Trade

Stock:
Travere Therapeutics
(TVTX)
Rating:Informative Sell
Date:Jan 08, 2018 - Jan 08, 2019
Return:-0.50%
The most profitable trade made by Elizabeth Reed

Elizabeth Reed's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIGRQ
Eiger Biopharmaceuticals
$1.44K
Travere Therapeutics
Sep 09, 2024
SVP, GC & CORPORATE SECRETARY
Uninformative Buy
$1.40M
List of latest transactions for each holding click on a transaction to see Elizabeth Reed's performance on stock

Elizabeth Reed insider profile FAQ

What is the percentage of profitable transactions made by Elizabeth Reed?
The percentage of profitable transactions made by Elizabeth Reed is ―.
    What is the average return per transaction made by Elizabeth Reed?
    The average return per transaction made by Elizabeth Reed is ―.
      What stocks does Elizabeth Reed hold?
      Elizabeth Reed holds: EIGRQ, TVTX stocks.
        What was Elizabeth Reed’s latest transaction?
        Elizabeth Reed latest transaction was an Uninformative Buy of ―.
          What was Elizabeth Reed's most profitable transaction?
          Elizabeth Reed’s most profitable transaction was an Informative Sell of TVTX stock on January 8, 2018. The return on the trade was -0.50%.
            What is Elizabeth Reed's role in Eiger Biopharmaceuticals?
            Elizabeth Reed's role in Eiger Biopharmaceuticals is VP, General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.